Kendra D. Carter

Array ( [id] => 6234980 [patent_doc_number] => 20100266684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'METHOD AND COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT' [patent_app_type] => utility [patent_app_number] => 12/757824 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15579 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266684.pdf [firstpage_image] =>[orig_patent_app_number] => 12757824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6630123 [patent_doc_number] => 20100311697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Methods and Compositions for the Treatment of CNS-Related Conditions' [patent_app_type] => utility [patent_app_number] => 12/753769 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14679 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311697.pdf [firstpage_image] =>[orig_patent_app_number] => 12753769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8340198 [patent_doc_number] => 08242122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Method and compounds for inhibition of cell death' [patent_app_type] => utility [patent_app_number] => 12/751036 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18777 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12751036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056103 [patent_doc_number] => 20120077791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'NOVEL CRYSTALLINE FORM OF ANTIPROGESTIN CDB-4124' [patent_app_type] => utility [patent_app_number] => 13/256914 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4611 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077791.pdf [firstpage_image] =>[orig_patent_app_number] => 13256914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8607235 [patent_doc_number] => 20130012548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'DEUTERIUM-SUBSTITUTED OMEGA-DIPHENYLUREA AND DERIVATIVES THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/635446 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7682 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995079 [patent_doc_number] => 08518962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Use of opioid antagonists' [patent_app_type] => utility [patent_app_number] => 12/723339 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 21092 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12723339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9140348 [patent_doc_number] => 08580809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Filamin A-binding anti-inflammatory analgesic' [patent_app_type] => utility [patent_app_number] => 12/719589 [patent_app_country] => US [patent_app_date] => 2010-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44242 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12719589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442355 [patent_doc_number] => 20120258971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'THERAPEUTIC AGENT FOR CHRONIC PAIN' [patent_app_type] => utility [patent_app_number] => 13/395364 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1515 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6327130 [patent_doc_number] => 20100197628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'METHODS OF TREATING PSYCHIATRIC, SUBSTANCE ABUSE, AND OTHER DISORDERS USING COMBINATIONS CONTAINING OMEGA-3 FATTY ACIDS' [patent_app_type] => utility [patent_app_number] => 12/704964 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14464 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197628.pdf [firstpage_image] =>[orig_patent_app_number] => 12704964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231592 [patent_doc_number] => 20100184725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Method and Composition for Treating Alzheimer\'s Disease and Dementias of Vascular Origin' [patent_app_type] => utility [patent_app_number] => 12/698239 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7924 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184725.pdf [firstpage_image] =>[orig_patent_app_number] => 12698239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4485117 [patent_doc_number] => 07902246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Methods for controlling formation of imiquimod impurities for two months, four months, and six months' [patent_app_type] => utility [patent_app_number] => 12/698132 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7369 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902246.pdf [firstpage_image] =>[orig_patent_app_number] => 12698132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685309 [patent_doc_number] => 20100120832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'METHOD OF PREPARING A PHARMACEUTICAL CREAM AND MINIMIZING IMIQUIMOD IMPURITY FORMATION (AT LEAST FOUR MONTHS STORAGE)' [patent_app_type] => utility [patent_app_number] => 12/697434 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7360 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120832.pdf [firstpage_image] =>[orig_patent_app_number] => 12697434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4529771 [patent_doc_number] => 07923463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-12 [patent_title] => 'Methods for stabilizing imiquimod for two months, four months, and six months' [patent_app_type] => utility [patent_app_number] => 12/698123 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7366 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/923/07923463.pdf [firstpage_image] =>[orig_patent_app_number] => 12698123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685310 [patent_doc_number] => 20100120831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'METHODS FOR IMPROVING IMIQUIMOD AVAILABILITY AT TWO MONTHS, FOUR MONTHS AND SIX MONTHS BETWEEN REFINED AND COMPENDIAL' [patent_app_type] => utility [patent_app_number] => 12/697429 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7360 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120831.pdf [firstpage_image] =>[orig_patent_app_number] => 12697429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685308 [patent_doc_number] => 20100120833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'METHOD OF PREPARING A PHARMACEUTICAL CREAM AND MINIMIZING IMIQUIMOD IMPURITY FORMATION (AT LEAST SIX MONTHS STORAGE)' [patent_app_type] => utility [patent_app_number] => 12/697439 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7359 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120833.pdf [firstpage_image] =>[orig_patent_app_number] => 12697439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6591809 [patent_doc_number] => 20100130534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'METHODS FOR REDUCING IMIQUIMOD IMPURITIES FOR TWO MONTHS, FOUR MONTHS, AND SIX MONTHS' [patent_app_type] => utility [patent_app_number] => 12/698120 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7359 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130534.pdf [firstpage_image] =>[orig_patent_app_number] => 12698120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4485082 [patent_doc_number] => 07902242 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Method of stabilizing imiquimod' [patent_app_type] => utility [patent_app_number] => 12/697217 [patent_app_country] => US [patent_app_date] => 2010-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7366 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902242.pdf [firstpage_image] =>[orig_patent_app_number] => 12697217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537774 [patent_doc_number] => 20100204254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Use of statins in the prevention and treatment of radiation injury and other disorders associated with reduced endothelial thrombomodulin' [patent_app_type] => utility [patent_app_number] => 12/657915 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7386 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204254.pdf [firstpage_image] =>[orig_patent_app_number] => 12657915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685322 [patent_doc_number] => 20100120819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'METHOD OF REDUCING IMIQUIMOD IMPURITY FORMATION' [patent_app_type] => utility [patent_app_number] => 12/697163 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7360 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120819.pdf [firstpage_image] =>[orig_patent_app_number] => 12697163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6426445 [patent_doc_number] => 20100168198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Mitochondria-targeted antioxidant prodrugs and methods of use' [patent_app_type] => utility [patent_app_number] => 12/694337 [patent_app_country] => US [patent_app_date] => 2010-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12245 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168198.pdf [firstpage_image] =>[orig_patent_app_number] => 12694337 [rel_patent_id] =>[rel_patent_doc_number] =>)